Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
Eftimia Boutsikou,1 Theodoros Kontakiotis,1 Paul Zarogoulidis,1 Kaid Darwiche,2 Ellada Eleptheriadou,1 Konstantinos Porpodis,1 Grammati Galaktidou,3 Leonidas Sakkas,4 Wolfgang Hohenforst-Schmidt,5 Kosmas Tsakiridis,6 Theodoros Karaiskos,7 Konstantinos Zarogoulidis11Pulmonary Department-Oncology Unit...
Main Authors: | Boutsikou E, Kontakiotis T, Zarogoulidis P, Darwiche K, Eleptheriadou E, Porpodis K, Galaktidou G, Sakkas L, Hohenforst-Schmidt W, Tsakiridis K, Karaiskos T, Zarogoulidis K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-03-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/docetaxel-carboplatin-in-combination-with-erlotinib-andor-bevacizumab--a12334 |
Similar Items
-
New dilemmas in small-cell lung cancer TNM clinical staging
by: Zarogoulidis K, et al.
Published: (2013-05-01) -
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
by: Zarogoulidis K, et al.
Published: (2013-07-01) -
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
by: Zarogoulidis K, et al.
Published: (2013-10-01) -
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
by: Zarogoulidis P, et al.
Published: (2012-03-01) -
Carcinoma of Unknown Primary Site Treated with Carboplatin + Paclitaxel + Bevacizumab + Erlotinib and Its Maintenance Chemotherapy
by: Hirotoshi Yasui, et al.
Published: (2014-08-01)